Establishment of an antimicrobial stewardship strategy on the surgical NICU at Cairo University specialized pediatric hospital
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Jan 2020 · 1 min read
In brief
In brief
This prospective study demonstrates successful implementation of an antimicrobial stewardship program in a surgical neonatal ICU, achieving 86% guideline compliance and reducing surgical site infections to 20%. The intervention significantly decreased antibiotic usage, shortened hospital stays by 2.5 days, and reduced drug costs while improving patient outcomes.
Written by the GCMD Library team from the article.
Purpose
Antimicrobial resistance is a major concern that we are facing nowadays. This is due to antibiotic misuse and bacteria developing resistance to the commonly used antibiotics. This may lead to increased mortality and consumption of country resources. Implementation of an antimicrobial stewardship program [ASP] can limit the use of unnecessary antibiotics and subsequently decrease the infection rates with better patient outcome. We aimed to control antibiotic misuse, reduce infection rate, decrease drug costs, and reduce length of hospital stay in the ICU.
Methods
We conducted a prospective study on the surgical neonatal ICU [SNICU] over a period of 6 months divided into pre-implementation phase, followed by an ASP phase, in which we applied the antibiotic guidelines approved by the ASP committee. Data were collected in the two phases and analyzed for demographics, compliance with guidelines, prescribed antibiotics, lab investigations, surgical site infection [SSI], length of stay and patient outcome.
Results
Compliance to the guidelines was encountered in 86% and SSI rate decreased to 20%. Days of Therapy (DOT) per 1000 patient days showed a significant decrease in Ampicillin Sulbactam by 296 (p = 0.024), Imipenem by 220.34 (p = 0.024) and Vancomycin by 287.34 (p = 0.048). Drug cost showed a 1185.97 EGP decrease in the ASP period compared to the pre-implementation period (p = 0.714). Average LOS decreased in the ASP period by a mean difference of 2.5 (p = 0.027).
Conclusion
ASP implementation can control antibiotic misuse, decrease the medical care expenses and improve patient outcome.
Type of study
Clinical research paper.
Level of evidence
Level one.
